Cart
sales@molnova.com
Rezatomidine
CAS No. 847829-38-3
Rezatomidine( AGN-203818 | AGN203818 | AGN 203818 )
Catalog No. M28010 CAS No. 847829-38-3
Rezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 264 | Get Quote |
|
| 5MG | 403 | Get Quote |
|
| 10MG | 592 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1701 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRezatomidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
-
DescriptionRezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
-
In Vitro——
-
In Vivo——
-
SynonymsAGN-203818 | AGN203818 | AGN 203818
-
PathwayOthers
-
TargetOther Targets
-
RecptorBRM/BRG1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number847829-38-3
-
Formula Weight232.35
-
Molecular FormulaC13H16N2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@H](c1c[nH]c(=S)[nH]1)c1cccc(C)c1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neville John ANTHONY, et al. Compounds and uses thereof. WO2019152437A1.
molnova catalog
related products
-
Sodium benzoate
Sodium benzoate is a D-Amino Acid Oxidase Inhibitor.Sodium Benzoate is a Food Preservative.
-
Flutamide Related Co...
Used as pharmaceutical intermediates.
-
MTOB
MTOB is a substrate for c-terminal binding protein (CtBP) that interferes with the carcinogenic activity of CtBP in cell culture and mice. It also actively regulates TCF-4 signaling, leading to cancer stem cell (CSC) growth and self-renewal.
